期刊文献+

氟伏沙明联合氯米帕明治疗强迫症 被引量:5

氟伏沙明联合氯米帕明治疗强迫症
下载PDF
导出
摘要 目的:探讨分析氟伏沙明联合氯米帕明治疗强迫症的临床效果。方法:收治强迫症患者140例,平均分成两组,其中运用氟伏沙明治疗作为对照组,观察组则在对照组的基础上加用氯米帕明,比较两组治疗后的效果情况。结果:观察组总有效率88.6%,显效以上74.3%;而对照组总有效率81.4%,显效以上57.1%。另外,对照组和观察组在治疗前在Yale-Brown强迫量表、汉密顿抑郁量表、汉密顿焦虑量表上午明显差异性,P>0.05,以上情况两组间治疗后有明显的差异性,P<0.05有统计学意义。结论:氟伏沙明联合氯米帕明治疗强迫症效果明显,且安全性高。 Objective:The aim of the article was to investigate and analyze the clinical efficacy of fluyoxamine combined with clo- mipramine in the treatment of obsessive - compulsive disorder. Methods: Retrospec- tively analyze the clinical materials of 140 cases obsessive - compulsive disorder pa- tients from May 2011 to May 2012 in our hospital. They were divided into two groups. The control group were taken with fluyoxam- ine, and the observation group were taken with clomipramine on the control group ba- sis. Compare the efficacy after treatments. Results:The total efficacy of the observation group was 88.6% , above the significant effi- cacy was 74. 3%. While the control group separately were 81.4% and 57.1%. In ad- dition, the Yale - Brown obsessive compul- sive scale, Hamilton depression scale and Hamilton anxiety scale of the two groups be- fore treatments had no significant differences ( P 〉 0.05 ), but they had sigrlificant differ- ences after treatments ( P 〈 0.05 ), they had statistical significances. Conclusion : Fluyox amine combined with clomipramine was ob- viously effective and safe for the treatment of obsessive - compulsive disorder.
作者 王俊 刘建萍
出处 《中国社区医师(医学专业)》 2013年第3期116-117,共2页
关键词 氟伏沙明 氯米帕明 强迫症 临床效果 Fluvoxamine Clomipramine Obsessive -compulsive disorder Clinical ef-ficacy
  • 相关文献

参考文献5

二级参考文献22

  • 1喻东山.强迫症的药物治疗进展[J].中国全科医学,2009,12(8):663-665. 被引量:13
  • 2王来海,黄素培,潘保中.兰释[J].中国新药杂志,2004,13(7):657-659. 被引量:14
  • 3王国强,张亚林,杨世昌.强迫症患者中枢单胺类递质及神经肽研究进展[J].临床心身疾病杂志,2006,12(2):154-157. 被引量:20
  • 4李红远,刘富会,刘传芝,李瑞雪.氟伏沙明与氯丙米嗪治疗强迫症对照研究[J].临床心身疾病杂志,2007,13(3):224-225. 被引量:25
  • 5沈渔村.精神病学[M].北京:人民卫生出版社,1994.684-687.
  • 6Kennedy JS, Gwirtsman HE, Schmidt DE, et al. Serial cerebrospinal fluid tryptophan and 5hydroxy indoleacetic acid concentrations in healthy human subjects [ J ]. Life Sci, 2002,71 (14) :1703.
  • 7Ravindran L, Jung S, Ravindran A. Intravenous anti - obsessive agents : a review [ J ]. J Psychopbarmacol,2008,21:32 - 38.
  • 8Rojas - Corrales MO, Gibert - Rallola J, Mico JA. Role of atypical opiates in OCD. Experimental approach through the study of 5 - HT(2A/C) receptor - mediated behavior[ J]. Psychopharmacology ,2007,190:221 - 231.
  • 9Denys D. Pharmacotherapy of obsessive- compulsive disorder and obsessive - compulsive spectrum disorders [ J ]. Psychiatr Clin N Am, 2006, 29:553-584.
  • 10Mundo E,Bainchi L,Bellodi L.Efficacy of fluvoxamine,paroxetine and citalopram in the treatment of obsessive compulsive disorder:a single blind study[J].J Clin Psychophamacol,1997,17:267-271.

共引文献17

同被引文献19

引证文献5

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部